David Berd - Concepedia

Author

David Berd

Thomas Jefferson University ORCID

Also Known As

Berd, D D, Berd, David, D A Berd, D BERD, D Berd, D. A. BERD, D. Berd, DAVID BERD, David A. Berd, David Berd

156

Publications

5.5K

Citations

H-Index

102

Concepts

All Affiliations

Thomas Jefferson University Sidney Kimmel Cancer Center Jefferson College Wills Eye Hospital

About

David Berd is an author at Thomas Jefferson University specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	53	3.5K
2	Allergy	11	11	833
3	Health Sciences	4	4	265
4	Natural Sciences	4	4	215
5	Engineering	1	1	166

David Berd

Publications

Citations

H-Index

Page 1

	Year	Citations
Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients. David Berd, Henry Maguire, Peter A. McCue, Journal of Clinical Oncology ImmunologyPathologyVaccine TherapyImmunotherapyTumor Immunology	1990	298
Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. David Berd, Henry Maguire, Michael J. Mastrangelo PubMed ImmunologyImmunoeditingImmunotherapyAutologous Melanoma CellsAnimal Tumor Systems	1986	252
Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Masataka Ohta, Hirokazu Nagai, Makiko Shimizu, PubMed PathologyTumor BiologyOncologyMelanoma SusceptibilityCancer Cell Biology	1994	169
Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells. David Berd, Michael J. Mastrangelo PubMed Immune RegulationImmunologyImmunologic MechanismCd4 T Cell ResponsesImmunotherapeutics	1988	167
Laboratory Identification of Clinically Important Aerobic Actinomycetes David Berd Applied Microbiology BiologyAerobic ActinomycetesUnicellular OrganismMicrobial SystematicsEngineering	1973	166
Immunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine David Berd, Takami Sato, Henry Maguire, Journal of Clinical Oncology	2003	145
Regulation of intracellular pH in human melanoma: potential therapeutic implications. M Wahl, Judith A. Owen, Randy Burd, PubMed Inhibited MctDermatologyCancer BiologyCellular PhysiologyTumor Biology	2002	143
Augmentation of the human immune response by cyclophosphamide. David Berd, Michael J. Mastrangelo, Paul F. Engstrom, PubMed ImmunotoxicologyImmunologyImmune RegulationPathologyImmunophenotyping	1982	138
Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials Edward F. McCiay, Michael J. Mastrangelo, David Berd, International Journal of Cancer	1992	137
Protracted survival after resection of metastatic uveal melanoma Takekazu Aoyama, Michael J. Mastrangelo, David Berd, Cancer	2000	133

Page 1